Financial Incentives to Exercise for Adolescents
| Status: | Completed |
|---|---|
| Conditions: | Obesity Weight Loss, Endocrine |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 11 - 20 |
| Updated: | 4/5/2019 |
| Start Date: | May 2013 |
| End Date: | May 2017 |
Incentivizing Behavior: Promoting More Physical Activity in American Indian Youth
Among youth populations, American Indians have the highest prevalence of diabetes in the
United States. This study will use exercise as the principal lifestyle modification approach
to reduce the risk of diabetes in this population. The Choctaw Nation of Oklahoma has several
excellent, but underutilized wellness facilities in their Health Services Area in rural
Southeast Oklahoma, a low socioeconomic region. It has been established that exercise lowers
diabetes risk, and many overweight/obese, insulin resistant American Indian youth who live in
this region would benefit from an increase in regular exercise. The challenge is to modify
behavior so that routine exercise is established and maintained. The proposed study will test
whether monetary incentives can elicit greater frequency and duration of exercise in American
Indian youth when transportation and access barriers are reduced.
United States. This study will use exercise as the principal lifestyle modification approach
to reduce the risk of diabetes in this population. The Choctaw Nation of Oklahoma has several
excellent, but underutilized wellness facilities in their Health Services Area in rural
Southeast Oklahoma, a low socioeconomic region. It has been established that exercise lowers
diabetes risk, and many overweight/obese, insulin resistant American Indian youth who live in
this region would benefit from an increase in regular exercise. The challenge is to modify
behavior so that routine exercise is established and maintained. The proposed study will test
whether monetary incentives can elicit greater frequency and duration of exercise in American
Indian youth when transportation and access barriers are reduced.
Study participants in the intervention arm of the study will be asked to exercise on 3 days
per week for 48 weeks. Clinical and physical assessments will be performed at baseline and
after 16, 32 and 48 weeks. Participants will be randomized into one of two groups. Each group
will receive payment for exercise sessions completed but one group will be on a fixed
schedule of compensation and the other will have a schedule that incentivizes frequency or
duration of exercise. In addition, two reference groups of age-matched participants who are
normal weight and subclassified as having either low or high levels of physical activity and
fitness will be tested. The reference groups will complete baseline tests and will not enter
the exercise intervention program.
per week for 48 weeks. Clinical and physical assessments will be performed at baseline and
after 16, 32 and 48 weeks. Participants will be randomized into one of two groups. Each group
will receive payment for exercise sessions completed but one group will be on a fixed
schedule of compensation and the other will have a schedule that incentivizes frequency or
duration of exercise. In addition, two reference groups of age-matched participants who are
normal weight and subclassified as having either low or high levels of physical activity and
fitness will be tested. The reference groups will complete baseline tests and will not enter
the exercise intervention program.
Inclusion Criteria for exercise intervention cohort:
- 11.0-20.9 years old
- overweight or obese
- family history of diabetes (primary or secondary relative)
- not in sports or exercise program (3 or fewer days per week of moderate-to-vigorous
intensity physical activity, MVPA) for prior 3 months
- Tanner stage 2 or above
Inclusion Criteria for reference group cohort:
- 11.0-20.9 years old
- normal weight
- For low physical activity subgroup: not in sports or exercise program (3 or fewer days
per week of MVPA) for prior 3 months
- For high physical activity subgroup: >30 minutes of structured MVPA on >3 days/week
over the preceding 3 months
- Tanner stage 2 or above
Exclusion Criteria for all participants:
- metabolic, endocrine, cardiovascular, kidney disease
- orthopedic problems that limit physical activity
- medications or treatments that would interfere with the outcomes and interpretations
- smoking or tobacco use
- alcohol or illicit drug use
- pregnancy
We found this trial at
2
sites
Click here to add this to my saved trials
Hugo, Oklahoma 74743
Principal Investigator: Kenneth C Copeland, MD
Phone: 405-271-8001
Click here to add this to my saved trials